Association of GSTM1 and GSTT1 Null Genotypes with Disease Severity and Serum Cytokine Levels in Hospitalized COVID-19 Patients
Authors:
- Boban StolićBSBoban Stolić
- Nataša KatanićNKNataša Katanić
- Bojan JoksimovićBojan Joksimović
- Jelena FilimonovićJFJelena Filimonović
- Ksenija BojovićKBKsenija Bojović
- Aleksandar PavlovićAPAleksandar Pavlović
- Jasmina PolugaJPJasmina Poluga
- Nikolina Elez-BurnjakovićNENikolina Elez-Burnjaković
- Biljana MijovićBMBiljana Mijović
- Nenad LalovićNLNenad Lalović
- Milena AnđelkovićMAMilena Anđelković
- Milica MilentijevićMMMilica Milentijević
Open Access
Abstract
Background: The clinical course of COVID-19 is highly variable, ranging from asymptomatic infection to critical illness with hyperinflammation and multiorgan failure. Oxidative stress plays a central role in COVID-19 pathogenesis, and genetic polymorphisms in glutathione S-transferase (GST) enzymes, particularly GSTM1 and GSTT1 null genotypes, may impair antioxidant defense and exacerbate inflammatory responses. This study aimed to investigate the association of GSTM1 and GSTT1 null genotypes with both disease severity and serum cytokine levels in hospitalized COVID-19 patients. Methods: This cross-sectional study enrolled 137 COVID-19 patients hospitalized during the second pandemic wave (July–September 2020). Patients were stratified into mild (n = 67) and severe (n = 70) groups based on clinical criteria. GSTM1 and GSTT1 polymorphisms were determined by multiplex polymerase chain reaction. Serum levels of 13 cytokines were measured using flow cytometry. Logistic regression analyzed genotype associations with disease severity, and multivariate linear regression assessed relationships between null genotypes and pro-inflammatory cytokine levels (IL-6, TNF-α, IL-17A, IFN-γ), adjusted for age, sex, hypertension, and diabetes. Results: The GSTT1 null genotype was significantly associated with severe COVID-19 (adjusted OR = 2.56, 95% CI: 1.08–6.07, p = 0.032). Severe patients exhibited significantly elevated levels of IL-6 (75.6% increase, p = 0.008), TNF-α (69.4% increase, p = 0.005), IL-17A (54.4% increase, p = 0.016), and IFN-γ (10.1% increase, p = 0.021). Both GSTM1 and GSTT1 null genotypes were associated with higher levels of these cytokines, with stronger effects observed for GSTT1 null. In multivariate analysis, GSTT1 null independently predicted elevated IL-6 (β = 52.6, p = 0.003), TNF-α (β = 13.8, p = 0.002), IL-17A (β = 2.4, p = 0.001), and IFN-γ (β = 56.4, p = 0.012). The combined both null genotype showed the strongest associations but was limited by small sample size (n = 10) and should be interpreted with caution. Conclusions: The GSTT1 null genotype is associated with severe COVID-19 and appears to be associated with heightened pro-inflammatory cytokine responses, particularly IL-6, TNF-α, IL-17A, and IFN-γ. These findings suggest a potential role for genetic impairment of antioxidant defense may contribute to hyperinflammation in COVID-19 hyperinflammation, although validation in larger cohorts is needed.Keywords
This publication has 34 references indexed in Scilit:
- Delving deeper in the eye of the hurricane: Immunopathogenesis & molecular characterization of cytokine storm in COVID-19, association with disease severity & the therapeutic regimensCytokine, 2025
- Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severityGene, 2022
- Upregulation of oxidative stress gene markers during SARS-COV-2 viral infectionFree Radical Biology and Medicine, 2021
- Association of GSTM1 and GSTT1 gene polymorphisms with COVID‐19 susceptibility and its outcomeJournal of Medical Virology, 2021
- Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): Gender and age influencesMedical Hypotheses, 2020
- An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19Clinica Chimica Acta, 2020
- Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) InfectionArchives of Medical Research, 2020
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor systemCytokine & Growth Factor Reviews, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) studyAtherosclerosis, 2003